Answers are grounded in this paper and cite their sources.
Background: Human coagulation factor IX (hFIX) is a glycoprotein with two N-glycosylation sites at the activation peptide. Since the activation peptide is removed in mature hFIX, the exact role of N-glycosylation is unclear. To investigate the role of N-glycosylation in the secretion and activity of hFIX, we inhibited N-glycosylation by tunicamycin in the stable Human Embryonic Kidney (HEK)coagulation Factor IX (FIX) cells.
No takes yet. Share an insight, caveat, or question.
Khalilzadeh et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: